Efficacy and safety of anti-CD20 monoclonal antibody therapy for autoimmune nodopathies: a systematic review and meta-analysis
Efficacy Assessment The use of anti-CD20 monoclonal antibodies, particularly rituximab, has gained significant traction in the treatment of autoimmune nodopathies. […]

